RENAISSANCERE HOLDINGS LTD (RNR): what the price assumes

In the published model solve dated 2026-Q2, anchored at $323.59, RENAISSANCERE HOLDINGS LTD (RNR) is priced for 9.2% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/RNR

Headline

FieldValue
TickerRNR
CompanyRENAISSANCERE HOLDINGS LTD
Current price$323.59/sh
CompositionProperty 40% / Casualty and Specialty 60%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed9.2%
Return on equity now24.4%
ROE gap-15.2pp
Price-to-book1.21x

Solve inputs: computed at a 8.3% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.2pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.20σ
cohort percentile (of 88 peers)24
sustained it ~10 years at this level79%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.47x3justifies
Earnings0.71x1justifies
Relative0
Growth0

Families that justify the price: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.1%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$1156.750.28xyesTBVPS $284.52 × 4.07x (ROE (TTM) 22.3% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelativenoP/E 8.64x (blended: static sector reference 11x + trailing (TTM) 5x), scenarios: 7.3x / 8.6x / 10.0x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$685.270.47xyesBV/sh $284.52, ROE (TTM) 22.3%, ke 9.3%
Two-Stage Excess ReturnAsset$1058.500.31xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthnoRev $11.1B, growth -10% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.2x / 1.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelativenoEPS $42.13, growth 1% (input: historical EPS growth), PEG=3.95 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$519.330.62xyes√(22.5 × EPS $42.13 × BVPS $284.52) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsnoEPS $42.13 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelativenoEPS $42.13 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$455.460.71xyesEPS $42.13 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a funded financial business. Debt, interest, and cash flows are operating inputs, so industrial EV, net-debt, WACC, and free-cash-flow lenses do not apply; value the common-equity claim with book, earnings, capital, and payout economics.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Propertyfinancialequity$4.0bwithheldunresolved standalone equity facts required
Casualty and Specialtyfinancialequity$5.9bwithheldunresolved standalone equity facts required

No unit-level total common-equity value is stated. Each financial unit requires supported standalone common equity, normalized earnings, capital adequacy, and payout capacity. Consolidated debt, interest, and cash are operating balances, not an enterprise-to-equity bridge; company-level book, earnings, capital, and payout lenses remain the coherent cross-checks.

Solvency

FieldValue
Share count CAGR (buyback)-1.0%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Understanding where RenaissanceRe sits in its cycle is the whole bull case. This is a mature, highly profitable reinsurer in a period of strong underwriting returns, and the market is pricing it as though those returns are about to revert hard. The first quarter delivered operating income of $591 million, an operating return on equity of 22 percent annualized, and a company-wide adjusted combined ratio of 72 percent, meaning it kept 28 cents of every premium dollar after losses and expenses. The Property Catastrophe segment ran an adjusted combined ratio near 19 percent, the kind of margin that only a top-tier catastrophe underwriter in a benign-loss quarter produces. Earning a 24 percent return on equity while trading at 1.2 times book is the central mispricing the bull points to.

The business is also better diversified than the catastrophe label implies. RenaissanceRe runs two engines, Property and a larger Casualty and Specialty segment, and the casualty book has been growing in areas like its mortgage and credit lines even as it manages cyber-rate pressure. That mix smooths the inherent lumpiness: in light-catastrophe years the other property and casualty lines carry a greater share of the result, while in heavy years the catastrophe book is where the company is paid for taking the risk. The favorable reserve development of roughly $160 million in the quarter is the mark of a reserving culture that sets aside conservatively and releases later, the same discipline that lets a reinsurer compound book value through cycles.

The capital story is disciplined rather than promotional. Gross premiums written fell 16 percent, which a weaker company would lament but which here reflects deliberate portfolio reshaping and a refusal to chase softening rates, exactly the behavior that protects returns when pricing turns. Tangible book value per share rose even after returning capital, net investment income reached $304 million as higher yields flow through the portfolio, and the share count is essentially flat. The valuation methods are emphatic: the book-value-plus-profitability and earnings methods land at multiples of the price, with several reading the stock at well under half of their estimates. A best-in-class reinsurer earning 24 percent on equity, reshaping its book to defend that return, and trading near book value is the value-and-quality combination the bull case is built on.

Bear Case

The external variable with the most leverage on RenaissanceRe is the one no model can forecast: catastrophe losses. The price embeds only a roughly 9 percent return on equity even though the company has recently earned 24 percent, and that wide gap is the market's way of pricing the risk that a single bad season erases a year of profit. A property-catastrophe reinsurer is, by construction, short the tail: it collects premiums in calm years and pays out in violent ones, and a major hurricane or earthquake season can swing the result from a 22 percent return on equity to a loss. The first quarter's 19 percent property-catastrophe combined ratio was the benign-loss version of the business; the same book in a heavy year looks entirely different. The low priced-in return is not the market doubting the franchise; it is the market refusing to capitalize peak-cycle earnings.

The pricing cycle is the slower-moving version of the same risk. Gross premiums written fell 16 percent, partly deliberate but partly a response to softening rates, and the company's own filing describes "a decrease of $202.9 million, or 11.1%, in the other property class, primarily reflecting premium adjustments, in part due to rate decreases in the excess" lines. Reinsurance is cyclical: years of strong returns attract capital, capital drives down rates, and rates eventually compress returns toward the cost of capital. RenaissanceRe is disciplined enough to shrink rather than underwrite at inadequate prices, but a shrinking book still means less premium earning the high margins, and the 24 percent return on equity is a cycle peak, not a baseline.

The casualty side carries its own quieter risk. The casualty and specialty segment ran an adjusted combined ratio near 99 percent in the quarter, barely profitable on underwriting, and the filing notes pressure "in the casualty lines of business and changes in premium estimates on business underwritten in prior years", including rate pressure in cyber. Casualty reserves are long-tail and can develop adversely years after the premium is booked, the opposite of the favorable development the property book just enjoyed. The methods read the static value as cheap precisely because they capitalize the current high return, but the bear's point is that the return is the most cyclical, catastrophe-exposed, and reserve-sensitive in all of insurance, and paying even 1.2 times book asks the buyer to accept that volatility for a return that history says compresses.

Valuation

An insurer is worth the return it earns on its capital, so RenaissanceRe is read off price-to-book. At today's price the market is paying about 1.2 times book and assuming the company sustains a return on equity of only about 9 percent, far below the roughly 24 percent it has recently earned. The gap between those two numbers is the entire valuation question: the company is currently earning more than 2.5 times the return the price requires, and the price-to-book sits in the lower half of the peer group.

The methods read the stock as decidedly value-supported. The book-value-plus-profitability methods, built on book value near $270 a share and a 24 percent return on equity, land at multiples of the price, and the relative-multiple and earnings methods also sit well above it; only the forward-growth method reads the price as expensive, which is unsurprising for a business whose premiums are deliberately shrinking. The pattern, every static method calling the stock cheap and only the growth lens demanding, is the signature of a high-return name the market is unwilling to capitalize at its current earnings because it knows those earnings are cyclical.

For a reinsurer the balance sheet is the capital backing the risk, not corporate leverage, and the relevant read is capital strength and return capacity rather than debt and coverage. There RenaissanceRe is strong: tangible book value per share grew even after returning capital, the share count is essentially flat, and net investment income of $304 million adds a steady second profit stream alongside underwriting. The price is underwriting a sharply lower return than the company is producing, which means the buyer is being paid to accept catastrophe and cycle risk. The reason the discount exists is the volatility; the reason it may be a bargain is that disciplined reinsurers have historically out-earned what their book multiples assumed.

Catalysts

The first quarter was a strong, light-loss result. RenaissanceRe reported operating income of $591 million, net income available to common shareholders of $284.5 million, an operating return on equity of 22 percent annualized, and operating earnings per share of $13.75. The company-wide adjusted combined ratio was 72 percent, with Property Catastrophe at roughly 19 percent and Casualty and Specialty near 99 percent, and underwriting income reached $589 million including about $160 million of favorable reserve development; net investment income was $304 million.

The forward signals are the pricing cycle and the catastrophe season. Gross premiums written fell 16 percent to $3.4 billion, reflecting competitive rate pressure and deliberate portfolio reshaping, and tangible book value per share rose 1.5 percent to $233.49. The catalysts to watch are the mid-year reinsurance renewals and how rates hold, the Atlantic hurricane season that determines whether the benign-loss start to the year persists, and casualty reserve development given the rate pressure the company has flagged. A quiet catastrophe year would let the high returns compound into book value; a heavy one is the risk the discounted multiple is pricing.

Peer Cohorts (Per Segment, With Filing Citations)

Property (reported)

Casualty and Specialty (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

RNR Q1 2026 results, April 2026 · RNR Q1 2026 results

View the full interactive RNR report on boothcheck